Innoterra Bioscience Private Limited, a active private limited company, was established on 02 July 2010 in Mumbai, Maharashtra, India. Engaging in it consulting & support services within the information and communication sector, it holds CIN: U20211MH2010PTC205170. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹16.50 Cr and a paid-up capital of ₹15.88 Cr.
Formerly known as Innoterra Tech India Private Limited, Lateral Praxis (India) Private Limited. It upholds a compliant status. Its leadership includes Kasinathan Krishna Kumar Avinash (Director), Ankur Tripathi (Additional Director), Shubhda Nautiyal (Additional Director). Past directors included Suniti Gupta, Pablo Erat, Anup Subhash Karwa. It holds no open charges and ₹1.50 M settled loans. Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at Unit 801-802, 8Th Floor, Tower 1, One International Center,, Senapati Bapat Marg, Prabhadevi,, Mumbai, Maharashtra, 400013.
U20211MH2010PTC205170
205170
02 July 2010
₹16.50 Cr
₹15.88 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Innoterra Bioscience Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kasinathan Krishna Kumar Avinash | Director | 12 Jul 2024 | Current |
| Ankur Tripathi | Additional Director | 30 Jul 2025 | Current |
| Shubhda Nautiyal | Additional Director | 01 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 May 2020 | Past |
| Pramod Abcsdd | Additional Director | 08 Aug 2022 | Past |
| Pramod Abcsdd | Additional Director | 10 Jul 2023 | Past |
| Pramod Abcsdd | Director | 07 Jul 2010 | Past |
| Pramod Abcsdd | Additional Director | 29 Dec 2020 | Past |
| Pramod Abcsdd | Director | 18 Mar 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Innoterra Bioscience Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 40.88% decrease. The company also saw a substantial improvement in profitability, with a 69.43% increase in profit. The company's net worth Soared by an impressive increase of 81.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Innoterra Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2011 | Bank Of India | ₹1.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Innoterra Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Innoterra Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innoterra Bioscience's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Innoterra Bioscience Private Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Shubhda Nautiyal was appointed as a Additional Director was appointed as a Additional Director on 01 Aug 2025 & has been associated with this company since 4 months 30 days . was completed.
The activity Ankur Tripathi was appointed as a Additional Director was appointed as a Additional Director on 30 Jul 2025 & has been associated with this company since 5 months 1 day . was completed.
Innoterra Bioscience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
The activity Dhanashree Shrinath Bhairi was appointed as a Company Secretary was appointed as a Company Secretary on 10 Mar 2025 & has been associated with this company since 9 months 21 days . was completed.
Kasinathan Krishna Kumar Avinash was appointed as a Director was appointed as a Director on 12 Jul 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.
The CIN of Innoterra Bioscience Private Limited is U20211MH2010PTC205170.
Innoterra Bioscience Private Limited is headquartered at Unit 801-802, 8Th Floor, Tower 1, One International Center,, Senapati Bapat Marg, Prabhadevi,, Mumbai, Maharashtra, 400013.
Innoterra Bioscience Private Limited was incorporated on 02 July 2010.
The current directors of Innoterra Bioscience Private Limited are
The primary industry of Innoterra Bioscience Private Limited is Information And Communication.
Innoterra Bioscience Private Limited is unlisted.
The authorized capital of Innoterra Bioscience Private Limited is ₹16.50 Cr, and the paid-up capital is ₹15.88 Cr.
The compliance status of Innoterra Bioscience Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX